Recombinant Human Erythropoietin market

Recombinant Human Erythropoietin (rhEPO) Market - Global Outlook and Forecast 2022-2028

  • 03 March 2022
  • Life Sciences
  • 78 Pages
  • Report code : PMR-6915598

  • 4.7 (158)

Recombinant Human Erythropoietin Market

COMPANIES COVERED

3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma

Download FREE Report Sample

  Download Free sample

The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.

Recombinant Human Erythropoietin Market contains market size and forecasts of Recombinant Human Erythropoietin (rhEPO) in global, including the following market information:

Global Recombinant Human Erythropoietin (rhEPO) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Recombinant Human Erythropoietin (rhEPO) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Recombinant Human Erythropoietin (rhEPO) companies in 2021 (%)

The global Recombinant Human Erythropoietin (rhEPO) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ESRD Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Human Erythropoietin (rhEPO) include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Wesurveyed the Recombinant Human Erythropoietin (rhEPO) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Human Erythropoietin (rhEPO) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant Human Erythropoietin (rhEPO) Market Segment Percentages, by Type, 2021 (%)

ESRD

Cancer

HIV

Wounds and Neural Disease

Global Recombinant Human Erythropoietin (rhEPO) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant Human Erythropoietin (rhEPO) Market Segment Percentages, by Application, 2021 (%)

Hospitals

Retail Pharmacies

Global Recombinant Human Erythropoietin (rhEPO) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant Human Erythropoietin (rhEPO) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Human Erythropoietin (rhEPO) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Recombinant Human Erythropoietin (rhEPO) revenues share in global market, 2021 (%)

Key companies Recombinant Human Erythropoietin (rhEPO) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Recombinant Human Erythropoietin (rhEPO) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

3SBio

Shanghai Chemo

Chengdu Diao

NCPC Genetech

Kyowa Hakko Kirin

Shandong Kexing

Ahua Pharmaceutical

Biosidus

Dragon Pharma

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Recombinant Human Erythropoietin Market

Leave This Empty: